NCT01518387View on ClinicalTrials.gov

Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Hyperphosphatemia
Interventions
DRUG

Lanthanum Carbonate (BAY77-1931)

Trial Locations (11)

815-0082

Fukuoka

500-8717

Gifu

730-8655

Hiroshima

070-0030

Asahikawa

247-0072

Kamakura

238-0011

Yokosuka

989-6117

Ōsaki

981-0912

Sendai

700-0013

Okayama

770-0011

Tokushima

153-0061

Meguro-ku

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY